Royce & Associates LP Lexicon Pharmaceuticals, Inc. Transaction History

Royce & Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$1.05 - $3.67 $12,961 - $45,302	-12,344 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$1.44 - $2.1 $1,634 - $2,383	1,135 Added 10.13%	12,344 $18,000
Q2 2020 Aug 07, 2020	BUY	$1.75 - $2.3 $1,785 - $2,346	1,020 Added 10.01%	11,209 $22,000
Q1 2020 May 12, 2020	BUY	$1.8 - $4.28 $8,584 - $20,411	4,769 Added 87.99%	10,189 $20,000
Q4 2019 Feb 06, 2020	BUY	$3.16 - $5.15 $17,127 - $27,913	5,420 New	5,420 $22,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.